Buprenorphine

Overview

4.6 out of 5 (112 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Buprenorphine, a synthetic opioid, treats pain, and opioid use syndrome. It was developed in the late 1960s. It is a synthetic analog of thebaine, which is an alkaloid compound derived from the poppy flower. It is a Schedule III drug, which means that it has some potential for moderate or low physical dependence or high psychological dependence. This activity reviews the mechanism of action, adverse event profile, toxicity, dosing, pharmacodynamics, and monitoring of buprenorphine, pertinent for members of the interprofessional team for the treatment of patients where pain control or opioid misuse is an issue.

This course meets the new DEA requirement for the Mainstreaming Addiction Treatment (MAT) Act.

UAN: JA4008338-0000-23-867-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the mechanism of action of buprenorphine.
  • Outline the indications for the use of buprenorphine.
  • Explain the potential adverse effects of buprenorphine.
  • Summarize interprofessional team strategies for improving care coordination and communication to advance pain control and limit opioid misuse and improve outcomes when using buprenorphine.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-867-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Jane O. on 4/12/2021

Melanie D. on 9/25/2022

Lauralea T. on 6/20/2021

Makenzie L. on 6/21/2021

Julie G. on 6/24/2021

William E. on 8/17/2021

Daniel T. on 8/24/2021

Theresa B. on 8/26/2021

Kelsey G. on 8/29/2021

Zinon P. on 8/31/2021

Kelli H. on 9/20/2021

Crista B. on 10/4/2021

Erik D. on 10/20/2021

Rachael S. on 10/24/2021

Mary C. on 11/10/2021

ANWAR S. on 11/17/2021

Justine W. on 1/4/2022

Frank F. on 12/29/2021

Thank you.

Douglas T. on 12/27/2021

Melanie G. on 1/21/2022

elizabeth d. on 2/10/2022

Rodabeh M. on 2/20/2022

Jane O. on 3/7/2022

Linda P. on 3/6/2022

Terri C. on 3/6/2022

SANTHA A. on 3/15/2022

Cynthia F. on 3/18/2022

Jinelle S. on 3/29/2022

Charlene N. on 4/15/2022

MARC M. on 4/17/2022

Melissa D. on 4/27/2022

Lisa E. on 5/10/2022

Kyle P. on 5/13/2022

Brian K. on 5/16/2022

Megan G. on 5/18/2022

Lauren I. on 5/28/2022

lesha s. on 6/13/2022

James P. on 6/23/2022

Cameron G. on 6/25/2022

Autumn M. on 6/30/2022

Ashley M. on 7/7/2022

Linda W. on 7/24/2022

Spencer a. on 9/20/2022

Eli N. on 9/23/2022

Carrie H. on 10/3/2022

Christine G. on 10/5/2022

Laurie C. on 10/9/2022

Kathleen P. on 10/31/2022

Steven F. on 11/16/2022

Anne D. on 11/18/2022

Ketan H. on 11/24/2022

Keeon Z. on 11/25/2022

Caroline C. on 12/1/2022

Well done!

Jessica Z. on 12/12/2022

Dr M. on 12/27/2022

Kim B. on 12/29/2022

Jihye J. on 1/3/2023

Christina C. on 1/4/2023

THEODORE T. on 1/8/2023

Austin S. on 1/17/2023

Jeffrey H. on 2/25/2023

Jennifer A. on 2/4/2023

Attila G. on 2/10/2023

Wayne S. on 2/11/2023

Jordan A. on 3/19/2023

Michelle K. on 3/25/2023

Anne G. on 3/28/2023

guillaume c. on 4/1/2023

Masoud S. on 4/1/2023

Brendalla G. on 4/23/2023

Christopher W. on 4/24/2023

david l. on 4/25/2023

Susan H. on 4/28/2023

Kathryn P. on 4/29/2023

NICOLE R. on 5/12/2023

mariam g. on 6/5/2023

Wendy L. on 6/19/2023

Joseph F. on 6/14/2023

Caleb R. on 6/21/2023

Dana R. on 6/24/2023

Caleigh S. on 7/3/2023

Carson T. on 7/15/2023

Michelle T. on 7/20/2023

Hannah B. on 7/24/2023

Richard K. on 8/31/2023

Jama G. on 9/12/2023

Ali D. on 9/25/2023

Hannah C. on 9/26/2023

Scott S. on 9/26/2023

Ashley W. on 9/28/2023

The content is good and easy to read, not overwhelming.

Albin C. on 10/1/2023

daniel h. on 10/5/2023

Mary Y. on 10/15/2023

I think I understood the activity to say that a transdermal preparation of Buprenorphine is only available in Europe? Butrans is widely available in the US.

on 10/14/2023

Teresa R. on 10/16/2023

Caroline C. on 10/20/2023

Stephen B. on 10/21/2023

Mary C. on 10/21/2023

Stephen N. on 10/24/2023

good addition to course listings

Otto S. on 10/29/2023

Kery F. on 10/31/2023

Hannah J. on 11/10/2023

Kristen R. on 11/6/2023

Michael M. on 11/7/2023

Tanya O. on 11/10/2023

Denise W. on 11/11/2023

Lance H. on 11/13/2023

Carol D. on 11/14/2023

Robert R. on 11/15/2023

steve k. on 11/16/2023

james m. on 11/23/2023

Denise M. on 11/27/2023

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6763 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8033 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user